Cite Filings / SGP / 0001346824-26-000061
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13D

Beneficial Ownership Report

SpyGlass Pharma, Inc. · Filed 2026-02-17 · Acc 0001346824-26-000061

Documents 1

  • SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

  • 2026-02-17 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-02-17 SCHEDULE 13D Beneficial Ownership Report
  • 2026-02-13 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-02-13 8-K Executive or director change
  • 2026-02-13 SCHEDULE 13D Beneficial Ownership Report
  • 2026-02-13 SCHEDULE 13D Beneficial Ownership Report
  • 2026-02-11 4 Director bought 135,000 shares at $16.00 ($2,160,000)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…